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Abstract
Background: Melanomas are rare in cats. The eye is the most commonly involved site, whereas few data are
available about feline non-ocular melanomas (NOMs). Ki-67 thresholds with prognostic relevance have been
established for canine melanomas, but not in cats. This study was undertaken to investigate the relationship
between Ki-67 index, tumour characteristics, and clinical outcome in feline NOMs.
Histologic samples were retrospectively reviewed. Amelanotic tumours were admitted upon immunohistochemical
positivity for Melan A or S100. Evaluated parameters included morphological diagnosis, histotype, junctional activity,
degree of pigmentation, vascular invasion, lymphocytic infiltrate, necrosis, mitotic count (MC) and Ki-67 index.
Pigmented tumours were bleached before evaluation. Clinical and follow-up information were retrieved via
telephone interviews with the referring veterinarians.
Results: Fifty tumours located in skin (n = 33) and mucosae (n = 17) were included. Forty-eight percent and 95% of
amelanotic tumours (n = 21) stained positive for Melan A and S100, respectively. Most achromic tumours were
mucosal (P < 0.001, Fisher’s exact test) and presented a spindle cell morphology (P = 0.002; Fisher’s exact test). MC
and Ki-67 index were significantly correlated (P < 0.001; R = 0.67; Spearman’s rank correlation); median values were
15 (range, 0–153) and 28% (range, 1–78%), respectively. Both were significantly higher in spindle cell melanomas, in
tumours lacking junctional activity and in poorly-pigmented tumours. Follow-up information was available for 33
cats (66%). Variables related with a poor clinical outcome included mucosal location, tumour size, spindle, balloon
and signet ring cell histotypes, low pigmentation, MC > 5, Ki-67 > 20% and lack of treatment administration. On
multivariable analysis, only tumour histotype and treatment retained prognostic significance.
Conclusions: Although the majority of feline NOMs behave aggressively, Ki-67 index, together with other
parameters, may contribute to prognostic assessment. Prospective studies on homogeneous populations are
warranted to identify reliable threshold values for this marker.
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Background
Non-ocular melanocytic neoplasms (NOMs) are extremely
rare in cats, accounting for 2.7% of all skin tumours and
less than 1% of oral tumours [1, 2].
The few studies reporting the clinical evolution of
NOMs and investigating factors of potential prognostic
interest have so far generated conflicting results [1, 3–6].
The most cited parameters associated with a worse
outcome include eyelid or mucosal location, achromic
phenotype and epithelioid morphology [1, 3, 4, 6] whereas
tumours arising on the ear pinna may exhibit a more
favourable prognosis [4].
The relative number of tumour cells positive for the
nuclear protein Ki-67 (Ki-67 index, tumour growth
fraction) is an acknowledged prognostic factor for canine
melanoma [7–9]. In this species, the Ki-67 index has
been demonstrated to be significantly different between
benign and malignant melanocytic neoplasms, and
* Correspondence: silvia.sabattini@unibo.it
1Department of Veterinary Medical Sciences, Alma Mater Studiorum
University of Bologna, Via Tolara di Sopra, 50, 40064 Ozzano Emilia, (BO), Italy
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sabattini et al. BMC Veterinary Research  (2018) 14:309 
https://doi.org/10.1186/s12917-018-1639-1
negatively correlated with survival. Consequently,
thresholds holding a prognostic value have been estab-
lished for both cutaneous and oral canine melanocytic
neoplasms, and the assessment of the growth fraction
has become part of the routine histology practice for
these tumours [7–9].
This is the first study investigating the relevance of the
growth fraction in feline melanocytic tumours. The
primary goal was to evaluate the relationship between
Ki-67 index and tumour characteristics, including ana-
tomic location, size, histologic malignancy, predominant
histotype and mitotic count. Secondly, we aimed to
evaluate whether the Ki-67 index was related to clinical
outcome and survival times in a subset of cats with
available follow-up information.
Results
Demographic information and tumour characteristics
Fifty feline melanocytic tumours fulfilled the inclusion
criteria. Breeds included 42 Domestic Shorthairs, 3
Persians, 2 Siamese, 1 Maine Coon, 1 Devon Rex and 1
Chartreux. There were 26 castrated males (52%) and 24
spayed females (48%), with a mean age of 11 ± 4 years
(range, 2–19). Information regarding hair colour and
living environment were available for 33 cats (66%).
Most represented coat colours included grey tabby
(n = 10), red tabby (n = 8), black solid or bicolor
black-white (n = 5), brown tabby (n = 4) and calico
(n = 4). Cats had outdoor access in 18 out of 33 cases
(54%).
Thirty-three tumours (66%) were located in the skin;
including ear pinna (n = 7), eyelids (n = 4), face (n = 4),
trunk (n = 11), limbs (n = 3) and digits (n = 4). Eleven
out of 20 (55%) of these cats had no outdoor access.
Seventeen tumours (34%) were in a mucosal location or
in a mucocutaneous junction (oral mucosa, n = 10; lip,
n = 6; nasal mucosa, n = 1). Median tumour diameter
before fixation was 1.3 cm (range, 0.3–4). Regional
lymph node metastases had been cytologically or histo-
logically identified at diagnosis in 5 cutaneous melano-
mas (2 digital and one each on eyelid, ear pinna and
trunk).
Histology and immunohistochemistry
Forty-three cases (86%; 27 cutaneous and 16 mucosal)
were diagnosed as malignant melanomas and 7 (14%; 6
cutaneous and 1 oral) as melanocytomas. According to
the prevalent histotype, there were 12 epithelioid, 8
spindle cell, 5 balloon cell, 1 signet ring cell and 17
mixed melanomas (Figs. 1, 2 and 3). Melanocytomas
belonged to the composite epithelioid (n = 3) or mixed
(n = 4) subtypes. Twenty-one tumours (42%) were
completely amelanotic; all but one of them (95%) were
positive to S100, whereas 10 cases (48%) expressed
Melan A, including the S100-negative tumour. The
remaining tumours, including all the melanocytomas,
had either a degree of pigmentation below (n = 18; 36%)
or above (n = 11; 22%) 50%. Seventy-six percent of the
mucosal tumours were achromic versus 24% of the
cutaneous tumours (P < 0.001; Fisher’s exact test).
Eighty-seven percent of spindle cell melanomas were
amelanotic versus 25% of epithelioid or mixed types
(P = 0.002; Fisher’s exact test).
Junctional activity, lymphocytic infiltrate and necrosis
were observed in 34%, 38% and 16% of cases, respect-
ively. Vascular invasion was identified in 7 tumours
(14%) with epithelioid or balloon cell differentiation
(Table 1).
Median MC and Ki-67 index were 15 (range, 0–153)
and 28% (range, 1–78%), respectively. These parameters
were correlated (P < 0.001; R = 0.67; Spearman’s rank
correlation). MC was significantly higher in tumours di-
agnosed as malignant, in spindle cell tumours, in those
lacking junctional activity and in those with a percentage
of pigmented cells below 50%. Ki-67 index was signifi-
cantly higher in all of the above and in tumours larger
than 1.3 cm (Table 1).
Clinical course
Follow-up information was available for 33 cats (66%;
with 21 cutaneous and 12 oral tumours). Eighteen (54%)
underwent surgery; one received radiation therapy and 2
cats underwent a multimodal approach consisting of
radiotherapy plus dose-intense chemotherapy (carbopla-
tin, doxorubicin) and surgery plus metronomic chemo-
therapy (cyclophosphamide, thalidomide). In the cats
receiving surgery, margins were histologically clean in 14
cases (74%) and infiltrated in 5 (26%). The remaining 12
cats (36%) only received palliative care.
At the end of the study, 10 cats (30%) were alive, after
a median follow-up time of 140 days (95% CI, 64–401).
Four cats (12%) had died for tumour-unrelated causes
(chronic renal failure, n = 2; diabetes, n = 1; intestinal
mast cell tumour, n = 1) after a median of 656 days (95%
CI, 446–1175) and 19 cats (58%) had died of melanoma,
with a median OS of 150 days (95% CI, 94–206).
For both MC and Ki-67 index, it was not possible to
identify cut-off values to satisfactorily separate tumours
with benign and aggressive biologic behaviour. When
applying threshold values similar to those reported for
canine melanoma (5 for MC and 20% for Ki-67 index),
both were significantly associated with survival (Table 2).
Other variables significantly associated with shorter
survival times included mucosal location, large tumour
size, spindle, balloon or signet ring cell histotypes; less
than 50% of pigmented neoplastic cells and lack of treat-
ment (Table 2). Cats with clean surgical margin had a
significant better outcome than cats with infiltrated
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margins (P < 0.001; log-rank test) On multivariable
survival analysis, only tumour histotype and treatment
administration retained prognostic significance (Table 3).
Discussion
The majority of feline NOMs are reported to be malig-
nant, but definitive information about clinical and histo-
logic prognostic factors are lacking, mostly due to the
low frequency of these neoplasms.
This is the second largest study on feline NOMs and
the first investigating the prognostic relevance of Ki-67
in this species.
Although the observed age range was extremely wide,
the majority of subjects were aged, confirming previous
reports [1, 5, 10]. According to several authors, melano-
mas with primary auricular localization would affect
younger subjects and be associated with a better out-
come [1, 4–6]. This finding was not supported by our
results, since only one of 7 cats with pinnal melanoma
was under 10 years of age, and 3 cats out of 4 experi-
enced rapid disease progression.
Apparently, a greater proportion of feline malignant
melanomas arises in the skin, as compared with dogs,
and the involved region has not a prominent role in the
assessment of prognosis [1, 5]. Conversely, mucosal
location seems to be associated with a worse prognosis,
possibly due to a greater difficulty to obtain adequate
local tumour control.
While being an acknowledged promoting factor for
human and equine melanoma, ultraviolet (UV) light
exposure was only hypothesized to play a role in feline
cutaneous melanoma, mainly due to the common occur-
rence of these tumours on the head and ears [5, 6]. In
the present study, the 50% of cats with cutaneous melan-
oma had no outdoor access, making the causative role of
solar exposure less likely. Cats with orange, red, calico
Fig. 2 a Amelanotic spindle cell melanoma. HE, 400× magnification. b The same case after immunostaining for Melan A, demonstrating the
melanocytic nature of the tumour. Melan A IHC, haematoxylin counterstain, 200× magnification. c The same case after Ki-67 immunostaining.
MIB1 IHC, haematoxylin counterstain, 400× magnification
Fig. 1 a Heavily pigmented epithelioid melanoma. Haematoxylin and Eosin (HE), 400× magnification. b The same case after bleaching with
potassium permanganate and oxalic acid, showing several mitotic figures (arrowheads). HE, 400× magnification. c The same case after bleaching
and Ki-67 immunostaining. MIB1 immunohistochemistry (IHC), haematoxylin counterstain, 400× magnification
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or silver coat are associated with a higher incidence of
developing intraepidermal melanocytic hyperplasia
(lentigo) on their lips, gums, eyelids and/or nose [11].
This is a benign condition that has not been reported to
evolve to malignant melanoma, however, notably, 67% of
the cats in this study were the above colours.
Case-control studies could be helpful to clarify the role
of UV radiation and hair color in feline NOMs.
The elective therapy for feline melanoma remains
complete surgical excision. In the study by Chamel et al.,
(2016), cats undergoing surgery survived significantly
longer than those receiving no treatment or medical
treatment only. In the same study, complete surgical
margins were not associated with a survival advantage
[6]. In the present study, the median survival time of
subjects receiving treatment was 3 times higher than
those receiving a palliative treatment, but the presence
of clean surgical margins was significantly correlated
with a better prognosis.
Another previously reported negative prognostic factor
which was confirmed by our results is the lack of mel-
anin. The degree of pigmentation is a well acknowledged
prognostic factor also in canine melanoma [9]. Indeed,
the absence of melanin pigment could be associated with
loss of differentiation and acquisition of a molecular
phenotype with increased invasiveness and metastatic
potential [2, 6].
Completely amelanotic melanomas are likely under-
diagnosed in cats, due to difficulties in their identifica-
tion. Depending on their morphological features, they
can be misdiagnosed as undifferentiated carcinomas,
sarcomas or round cell tumours (e.g. lymphoma,
progressive histiocytosis, or atypical mast cell tumours).
In this study, immunohistochemical positivity to at least
one of Melan A and S100 was required for all amelanotic
tumours, even in the presence of convincing morpho-
logical features. These are the only validated markers to
confirm the melanocytic nature of a tumour in cats,
however their limited diagnostic utility is acknowledged
[6, 12]. As expected, less than 50% of amelanotic
melanomas in this study were positive for Melan A,
confirming the poor sensitivity of this marker. In
contrast, almost all the amelanotic melanomas stained
positively for S100, a highly sensitive but poorly
specific marker.
In the literature, epithelioid, spindle cell, mixed, signet
ring and balloon cell type of melanomas have been de-
scribed in cats [10]. The relevance of tumour histotype
in predicting the clinical behaviour of feline NOMs has
been disputed, with some authors reporting a worse
prognosis associated with epithelioid melanomas [4]. In
the present study, spindle, signet ring and balloon cell
histotypes were significantly associated with a poorer
prognosis in comparison with epithelioid and mixed
melanomas. Moreover, epithelioid tumours were charac-
terized by lower proliferative activity and a higher degree
of pigmentation.
Although Ki-67 index has been previously evaluated in
4 cats with ocular and extra-ocular melanomas [13], the
prognostic relevance of proliferative activity has never
been reliably assessed in this species. In the present
study, Ki-67 index was significantly correlated with other
prognostic variables, including tumour size, spindle cell
histotype, lack of pigmentation and MC, and values
greater than 20% were ultimately correlated with a worse
outcome. However, the same statistical correlations were
also observed for MC, suggesting that the immunohisto-
chemical assessment of Ki-67 index in feline NOMs may
not add much more to the plain assessment of MC on
HE-stained sections.
Fig. 3 a Amelanotic balloon cell melanoma. HE, 400× magnification. b The same case after immunostaining for S100, demonstrating the
melanocytic nature of the tumour. S100 IHC, haematoxylin counterstain, 200× magnification. c The same case after Ki-67 immunostaining.
MIB1 IHC, haematoxylin counterstain, 400× magnification
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Nevertheless, with both markers, we failed to iden-
tify a threshold value to satisfactorily identify tumours
with a worse clinical outcome and, after adjustment
with other clinicopathological variables in a multivari-
able model, prognostic significance was not retained.
It must be reminded that the retrospective setting of
this study resulted in not standardized staging
procedures, treatment plans and follow-up schedules,
making comparisons difficult. Almost all cats were
treated in first opinion practices by a wide range of
practitioners with different levels of experience,
reflecting the clinical management of the majority of
cats with this disease. Prospective studies are encour-
aged to assess the prognostic utility of the Ki-67
index on more cases with complete clinical staging,
receiving gold standard treatments and with long
term follow-up information.
Conclusions
This study confirms a poor prognosis of the majority
feline NOMs, although a certain degree of variability can
be observed, with a better outcome observed for small,
pigmented skin tumours removed with complete surgical
margins. Contrarily to previous studies, the epithelioid
morphology appears to be associated with a less
malignant biologic behaviour. MC and Ki-67 index may
contribute, with the aforementioned variables, to the
prognostic assessment of feline NOMs. Reliable thresh-
old values for both markers need to be identified in
prospective, standardized studies.
Methods
Inclusion criteria
Lesions histologically diagnosed as feline non-ocular
melanoma/melanocytoma or with melanoma among
Table 1 Relationship between proliferation indices (mitotic count and Ki-67 index) and clinicopathologic variables in 50 cases of
feline non-ocular melanocytic tumors
Variables Number of cases Median mitotic count (range) P Median Ki-67 index (range) P
Tumor location 0.396 0.984
skin 33 15 (0–153) 29% (1–78%)
mucosae 17 15 (2–48) 22% (10–68%)
Largest diametera 0.052 0.014*
≤ 1.3 cm 28 10 (0–40) 18% (1–78%)
> 1.3 cm 22 17 (3–153) 31% (14–77%)
Morphological diagnosis < 0.001* < 0.001*
melanocytoma 7 2 (0–4) 6% (1–18%)
melanoma 43 17 (1–153) 30% (6–78%)
Prevalent histotype 0.002* 0.005*
spindle cell 8 28 (16–153) 38% (20–54%)
others 42 12 (0–40) 25% (1–78%)
Junctional activity 0.005* 0.026*
present 17 11 (0–27) 22% (1–61%)
absent 33 21 (0–153) 32% (2–78%)
Pigmentation < 0.001* < 0.001*
≥ 50% 11 3 (0–27) 8% (1–29%)
< 50% or absent 39 17 (1–153) 31% (9–78%)
Vascular invasion 0.353 0.565
present 7 19 (4–36) 32% (10–47%)
absent 43 13 (0–153) 27% (1–78%)
Lymphocytic infiltrate 0.299 0.14
present 19 17 (2–40) 31% (11–78%)
absent 31 12 (0–153) 25% (1–68%)
Necrosis 0.166 0.29
present 8 22 (4–153) 33% (10–71%)
absent 42 13 (0–48) 27% (1–78%)
*Significant
aMedian value as cut-off
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differential diagnoses were retrospectively retrieved from
the archives of the pathology service of the Departments
of Veterinary Medical Sciences (University of Bologna,
Italy) and of Veterinary Sciences (University of Pisa,
Italy), and from a private veterinary diagnostic laboratory
(La Vallonea, Rho, Italy). Only primary tumours were
considered for inclusion: local recurrences and nodal/
distant metastases were removed from the selection.
Histologic sections from each case were reviewed for
diagnosis confirmation. Amelanotic tumours were in-
cluded only upon immunohistochemical positivity to at
least one melanocytic marker with validated diagnostic
utility in cats, including melan-A (1:400; A103 clone,
Dako, Glostrup, Denmark) and S100 (Catalogue number:
Z0311;1:2400; rabbit polyclonal, Dako) [12]. The immu-
nohistochemical analysis was performed as part of the
study at the Department of Veterinary Medical Sciences,
University of Bologna.
Histology
All samples for histologic examination were fixed in
10% neutered-buffered formalin, processed by routine
methods, embedded in paraffin wax, sectioned at
4 μm and stained with haematoxylin and eosin (HE).
The evaluated histologic features included morpho-
logical diagnosis (melanocytoma or malignant melan-
oma, according to the WHO guidelines) [14],
prevalent histotype (epithelioid, spindle cell, balloon
cell, signet ring cell or mixed), junctional activity, de-
gree of pigmentation (more than 50% of pigmented
cells, less than 50% or absent), vascular invasion,
lymphocytic infiltrate, necrosis and mitotic count
(MC). MC was assessed as the number of mitotic
figures in a 2.37 mm2 area (10 fields with a 40×
objective and a 10× ocular with a field number of
22 mm), according to the standards proposed by
Meuten et al., 2016 [15]. The count was performed in
Table 3 Multivariable analysis of variables potentially related to
overall survival (OS) in 33 cases of feline non-ocular melanocytic
tumors with available follow-up information
Variables Hazard ratio 95% CI P
Mucosal location 2.26 0.71–7.19 0.165
Largest diameter > 1.3 cma 3.46 0.7–17.06 0.128
Spindle-, balloon cell and
signet ring histotypes
3.48 1.04–11.57 0.042*
Pigmentation < 50% 1.69 0.09–32.56 0.730
Mitotic count >5b 6.77 0.36–128.02 0.202
Ki-67 index > 20%b 0.14 0.01–2.05 0.152
Lack of treatment 4.22 1.18–15.05 0.027*
CI confidence interval
*Significant
aMedian value
bcutoff value based on data analysis and canine melanoma literature
Table 2 Relationship between overall survival (OS) and
clinicopathological variables in 33 cases of feline non-ocular
melanocytic tumors with available follow-up information
Variables Number
of cases
Median OS
(95% CI)c
P
Tumor location 0.036*
Skin 21 197 (133–261)
Mucosae 12 72 (48–96)
Largest diametera 0.006*
≤ 1.3 cm 14 689 (79–1299)
> 1.3 cm 19 75 (11–139)
Morphological diagnosis 0.109
Melanocytoma 3 Not reached
Melanoma 30 156 (91–221)
Prevalent histotype 0.014*
Spindle, balloon and
signet ring cell
10 48 (0–115)
Epithelioid 9 689 (0–1444)
Mixed 14 156 (125–187)
Junctional activity 0.412
Present 10 136 (101–171)
Absent 23 197 (120–273)
Pigmentation 0.015*
≥ 50% 8 Not reached
< 50% or absent 25 119 (29–208)
Vascular invasion 0.809
Present 6 176 (0–405)
Absent 27 156 (77–235)
Lymphocytic infiltrate 0.838
present 12 176 (39–313)
absent 21 156 (92–219)
Necrosis 0.681
present 7 197 (48–346)
absent 26 156 (116–196)
Mitotic countb 0.013*
≤ 5 9 689 (0–1451)
> 5 24 119 (32–206)
Ki-67 indexb 0.036*
≤ 20% 10 689 (0–1460)
> 20% 23 119 (34–204)
Treatment < 0.001*
Yes 21 689 (12–1366)
No 12 59 (20–98)
CI confidence interval
*Significant
aMedian value
bCutoff value based on data analysis and canine melanoma literature
cDays
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10 consecutive non-overlapping high-power fields
(HPFs), starting from an area of high mitotic activity.
Fields with necrosis or inflammation were skipped.
All histologic evaluations were performed by consen-
sus by two of the authors (SS and AR).
Bleaching of melanin
The bleaching of melanin was performed on all the tu-
mours with approximately more than 25% of pigmented
cells before assessing MC and performing Ki-67 immu-
nohistochemistry (IHC).
Briefly, 4 μm tissue sections were exposed to treatment
with 2.5 g/L potassium permanganate (Merck, Darmstadt,
Germany) for 5 min, followed by 50 g/L oxalic acid
(Merck) for 5 min at room temperature.
To evaluate the effects of bleaching on tissue immuno-
reactivity, Ki-67 labelling was carried out on serial
sections of an amelanotic melanoma, with and without
bleaching. No differences in labelling intensity or distri-
bution were observed, and it was therefore concluded
that the bleaching method did not interfere with the
assessment of tumour growth fraction.
Ki-67 immunohistochemistry
Tumour sections were immunolabelled for Ki-67 by
using a commercial anti-human primary antibody
(MIB-1 clone, Dako) with validated reactivity in feline
tissues [16].
Endogenous peroxidase activity was blocked by
incubation for 30 mins with 0.3% hydrogen peroxide in
methanol. For antigen retrieval, slides were microwaved
in citrate buffer (pH 6.0) for 4 cycles of 5 mins, at 750 W.
Sections were incubated overnight at 4 °C in a humid
chamber with the primary antibody diluted 1:600 in a
blocking solution (10% goat serum in phosphate-buffered
saline). Binding sites of primary antibody were identified
using a biotinylated goat anti-mouse secondary antibody
(1:200 in blocking solution, Dako) with an incubation step
of 30 min at room temperature. Sections were then incu-
bated with a commercial streptavidin-biotin-peroxidase
kit (Vectastain Elite ABC Kit, Vector Laboratories,
Burlingame, CA, USA) and 3,3′-diaminobenzidine (DAB
tablets, Diagnostic BioSystems, Pleasanton, CA, USA) was
used as chromogen. Counterstain was performed with
Papanicolaou’s haematoxylin.
Feline intestinal mucosa was used as positive control
for MIB-1. Negative controls were obtained by omitting
the primary antibody.
The evaluation of Ki-67 immunolabelling was
performed by two authors (SS, MF), without knowledge
of the case outcome. Five high-power (400×) fields
selected within the areas of highest Ki-67 positivity were
photographed. Areas with severe inflammation or necrosis
were avoided. In every image, the number of neoplastic
cell nuclei with positive labelling and the total number of
neoplastic cells were assessed manually with a digital cell
counter (ImageJ, National Institutes of Health, Bethesda,
MD, USA). Ki-67 index was calculated as the mean per-
centage of labelled neoplastic cells in the 5 photographed
fields.
Clinical information
Patient records were reviewed to collect signalment,
tumour location and tumour size (largest diameter).
Referring veterinarians and/or owners were contacted
for additional information, including hair colour, living
environment (indoor/outdoor), clinical presentation, pres-
ence of metastases, treatment, survival and patient status.
The availability of these data was not among inclusion
criteria.
Statistical analysis
Data were analysed by use of a commercial software
program (SPSS Statistics v19, IBM, Armonk, NY, USA);
P values ≤0.05 were considered significant.
When appropriate, data sets were tested for normality
by use of the D’Agostino and Pearson omnibus normality
test. Values were expressed as mean ± standard deviation
in case of normal distribution, or as median with a range
in case of non-normal distribution.
The relationships between the following variables were
investigated: tumour location, tumour size, morpho-
logical diagnosis, prevalent histotype, junctional activity,
degree of pigmentation, vascular invasion, lymphocytic in-
filtrate, necrosis, MC and Ki-67 index. The distributions
of qualitative and quantitative variables were assessed by
Fisher’s exact test and Student’s T/Mann-Whitney U test,
respectively. The correlation between MC and Ki-67 index
was evaluated by means of the Spearman’s rank correl-
ation coefficient.
Overall survival (OS) was defined as the time (days)
from the date of diagnosis to the last reported date on
which the patient was seen alive. The patient status was
recorded as alive, dead because of melanoma-unrelated
causes or dead because of melanoma-related causes.
Survival estimates are presented as medians with the
corresponding 95% confidence intervals (95% CI).
The log-rank test was applied to compare survival
distributions. Single variables analysed for prognostic
relevance included tumour location, tumour size,
morphological diagnosis, prevalent histotype, junc-
tional activity, degree of pigmentation, vascular inva-
sion, lymphocytic infiltrate, necrosis, MC, Ki-67 index
and received treatment. Significant variables were fur-
ther tested in a multivariable Cox proportional hazard
model.
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